Oncolytics Biotech Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.04 |
1.21 |
1.56 |
54.33 |
162.62 |
309.19 |
| Przychód Δ r/r |
0.00% |
16.96% |
29.03% |
3373.33% |
199.33% |
90.13% |
| Przychód (min) |
1.04 |
1.21 |
1.56 |
54.33 |
162.62 |
309.19 |
| Przychód (max) |
1.04 |
1.21 |
1.56 |
54.33 |
162.62 |
309.19 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-32.04 |
-30.18 |
-30.62 |
-24.67 |
6.06 |
53.10 |
| Zysk netto % |
-3091.59% |
-2489.47% |
-1957.81% |
-45.40% |
3.73% |
17.18% |
| EPS (średnia) |
-0.42 |
-0.39 |
-0.40 |
-0.32 |
0.08 |
0.69 |
| Liczba analityków (Przychody) |
6 |
5 |
4 |
3 |
2 |
3 |
| Liczba analityków (EPS) |
2 |
3 |
3 |
1 |
1 |
1 |
| symbol |
ONCY |
ONCY |
ONCY |
ONCY |
ONCY |
ONCY |